Contact this trialFirst, we need to learn more about you.
NMDA Antagonist
NRX100 +1 More for Depression, Bipolar Disorder
Recruiting3 awardsPhase 3
Hollywood, Florida
This trial will test whether NRX-100, a drug that reduces symptoms of depression and suicidal ideation, is better than placebo in treating patients with severe bipolar depression and acute suicidal ideation or behavior.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.